» Articles » PMID: 16151014

Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients

Overview
Journal Science
Specialty Science
Date 2005 Sep 10
PMID 16151014
Citations 404
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphocyte egress from the thymus and from peripheral lymphoid organs depends on sphingosine 1-phosphate (S1P) receptor-1 and is thought to occur in response to circulatory S1P. However, the existence of an S1P gradient between lymphoid organs and blood or lymph has not been established. To further define egress requirements, we addressed why treatment with the food colorant 2-acetyl-4-tetrahydroxybutylimidazole (THI) induces lymphopenia. We found that S1P abundance in lymphoid tissues of mice is normally low but increases more than 100-fold after THI treatment and that this treatment inhibits the S1P-degrading enzyme S1P lyase. We conclude that lymphocyte egress is mediated by S1P gradients that are established by S1P lyase activity and that the lyase may represent a novel immunosuppressant drug target.

Citing Articles

Intrathymic Cell Migration: Implications in Thymocyte Development and T Lymphocyte Repertoire Formation.

Mendes-da-Cruz D, Lemos J, Belorio E, Savino W Adv Exp Med Biol. 2025; 1471:139-175.

PMID: 40067586 DOI: 10.1007/978-3-031-77921-3_5.


Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2.

Li H, Pike A, Chang Y, Prakaash D, Gelova Z, Stanka J Nat Commun. 2025; 16(1):721.

PMID: 39820269 PMC: 11739509. DOI: 10.1038/s41467-025-55942-7.


Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?.

Foran D, Antoniades C, Akoumianakis I Nutrients. 2024; 16(19).

PMID: 39408263 PMC: 11478599. DOI: 10.3390/nu16193296.


Deciphering the role of sphingosine 1-phosphate in central nervous system myelination and repair.

Binish F, Xiao J J Neurochem. 2024; 169(1):e16228.

PMID: 39290063 PMC: 11658189. DOI: 10.1111/jnc.16228.


Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors.

Foster D, Dunnavant K, Shrader C, LoPresti M, Seay S, Kharel Y J Med Chem. 2024; 67(13):11273-11295.

PMID: 38952222 PMC: 11247503. DOI: 10.1021/acs.jmedchem.4c00879.